Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140-2147

✍ Scribed by Bergenstal, R. M.; Rosenstock, J.; Arakaki, R. F.; Prince, M. J.; Qu, Y.; Sinha, V. P.; Howey, D. C.; Jacober, S. J.

• Book ID: 120656213
• Publisher: American Diabetes Association
• Year: 2013
• Tongue: English
• Weight: 48 KB
• Volume: 36
• Category: Article
• ISSN: 0149-5992
• DOI: 10.2337/dc13-0295